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Abstract In a number of experimental systems, the early stage 
of the apoptotic process, i.e. the stage which precedes nuclear 
disintegration, is characterized by the breakdown of the inner 
mitochondrial transmembrane potential (AWm). Here we address 
the question as to whether mitochondrial permeability transition 
(PT) pores may account for the A~IJ m dissipation in lymphocyte 
apoptosis. Drugs known for their PT-inhibitory potential 
(hongkrekic acid, cyclosporin A, and the non-immunosuppressive 
cyclosporin A analogue N-methyl-Val-4-cyclosporin A) are 
capable of preventing the apoptotic AWm disruption. Moreover, 
pharmacological modulation of PT-mediated A~]J m dissipation 
can prevent apoptosis. Thus, while suppressing the A~Fm 
disruption, bongkrekic acid also inhibits the apoptotic chroma- 
tinolysis. In conclusion, these data are compatible with the 
hypothesis that apoptotic AU?m disruption is mediated by the 
formation of PT pores and that PT-mediated A~Fm disruption is a 
critical event of the apoptotic cascade. 
Key words: T lymphocyte; Apoptosis; Mitochondrial 
transmembrane potential; Permeability transition; 
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1. Introduction 
Cells undergoing apoptosis exhibit a decrease in A~ which 
precedes nuclear signs of apoptosis [1 7]. This applies to nerve 
cell growth factor-deprived sympathetic neurons [1], p53- 
mediated cell death of fibroblasts [2], lymphocytes exposed 
to glucocorticoids or lethal antigen receptor-mediated activa- 
tion signals [3,4,6,8], and tumor necrosis factor-stimulated 
U937 cells [5,8]. Purification of cells with an abnormally low 
AWm (ate l°w cells) but still intact nuclei reveals that a reduc- 
tion in AWm accompanies an already irreversible step of apop- 
tosis. Thus, AUd~ow cells but not Avhlgh controls proceed to 
DNA fragmentation within 1 h of in vitro culture and later 
lose viability, even when the apoptosis inducing stimulus is 
withdrawn [3]. Apoptotic AW~ disruption is accompanied by 
an immediate shutdown of mitochondrial biogenesis [9]. Ac- 
cordingly, both the transcription of the mitochondrial genome 
[10] and the synthesis of mitochondrial proteins [2] are per- 
turbed early during the apoptotic process. Another conse- 
quence of AU?~ disruption is the uncoupling of oxidative phos- 
phorylation [2] and the generation of superoxide anion on the 
uncoupled respiratory chain [8]. Loss of mitochondrial func- 
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tion is also observed in anucleate cells induced to undergopro- 
grammed cell death [11,12], indicating that apoptotic altera- 
tions of mitochondrial function can occur in complete inde- 
pendence of the nucleus. 
Taken together, these observations suggest that early altera- 
tions of mitochondrial function may be important for the 
apoptotic process. In accord with this speculation, mitochon- 
dria are required in some cell-free systems to induce nuclear 
apoptosis [13]. To maintain the AUr'm, the inner mitochondrial 
membrane must be essentially impermeable for electrolytes. 
An abundant literature (reviewed in [14,15]) has established 
that experimental manipulation of isolated mitochondria can 
result in the formation of protaceous pores in the inner mi- 
tochondrial membrane that allow for the free distribution of 
solutes <1500 Da, thereby leading to the immediate dissipa- 
tion of the AWm. These pores are referred to as mitochondrial 
'megachannels' or 'permeability ransition' (PT) pores [14,15]. 
Recently, formation of PT pores has been involved in the 
post-ischemic or toxin-mediated death of myocardial cells 
and hepatocytes [16-22]. Prompted by these studies, we ad- 
dressed the question of whether PT might be responsible for 
the apoptotic AW~ disruption. To address this problem we 
have used two well-studied inhibitors of PT: cyclosporin A
and bongkrekic acid, a ligand of the adenine nucleotide trans- 
locator. We show here that these PT inhibitors prevent apop- 
totic AUdm dissipation. Moreover, we show that prevention of 
apoptotic AWm dissipation can actually inhibit apoptotic hro- 
matinolysis. These data suggest hat PT may be involved in 
the apoptotic ascade. 
2. Materials and methods 
2.1. Culture conditions and apoptosis induction 
Female BALB/c mice (6-10 weeks) received intraperitoneal (i.p.) 
injections of dexamethasone (DEX; 1 mg; Sigma, St. Louis, MO) 
or PBS as a vehicle control (200 p.1) [23]. Splenocytes were prepared 
on ice, depleted from erythrocytes by hypotonic lysis [24], and main- 
tained in complete culture medium (RPMI 1640 medium supplemen- 
ted with 10% FCS, L-glutamine, HEPES and antibiotics) at 0 to 4°C 
until labeling and analysis. Proliferation assays were performed on 
concanavalin A-stimulated (2 ktg/ml; Sigma) BALB/c splenocytes 
(2X 105 in 200 ktl medium, triplicates) cultured at 37°C for 72 h in 
Nunc fiat bottom 96 microtiter plates. For the assessment of DNA 
synthesis, cells were harvested after an 18 h pulse label with 1 ktCi of 
[3H]thymidine (Amersham, London, UK). 
2.2. Cytofluorometric analysis of mitochondrial transmembrane poten- 
tials, ROS generation, and nuclear DNA loss 
To evaluate mitochondrial transmembrane potentials (A~m) and 
superoxide anion generation, cells (5X105/ml) were incubated with 
3,3'-dihexyloxacarbocyanine iodide (DiOC6(3); Molecular Probes; 
40 nM in PBS) [3] and dihydroethidine (HE, 2 ktM) [8] for 15 min 
at 37°C followed by analysis on an Epics cytofluorometer (Coulter, 
Miami, FL). Forward and side scatters were gated on the major 
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Fig. 1. Effect of CsA on the Atl/m reduction accompanying early lymphocyte apoptosis. Splenocytes from DEX-primed BALB/c mice (1 mg 
i.p., 12 h before analysis) or vehicle controls were labelled with a mixture of DiOCr(3) (that measures AWm) and HE (that measures superoxide 
radical generation) for 15 min at 37°C immediately before cytofluorometric analysis (DiOC6(3) as green fluorescence and HE--, Eth conversion 
as red fluorescence). Purified cells from windows 1-3 were kept for 60 rain at 4 or 37°C, in the presence or absence of CsA (10 laM), followed 
by relabeling and reanalysis under identical conditions• Control cells were cultured uring 30 min with menadione (1 mM at 37°C) followed by 
DiOCr(3)/HE labelling (upper ight quadrant). Results are representative of four independent experiments. 
population of normal-sized lymphoid cells. In control experiments, 
cells were incubated with menadione (1 mM, Sigma), a drug that 
generates uperoxide anion and disrupt the AVm. The frequency of 
cells having undergone chromatinolysis (subdiploid cells) was deter- 
mined by ethanol permeabilization, followed by propidium iodine (PI) 
staining [25]. 
2.3. Functional studies of purified cell populations 
For cytofluorometric purification, splenocytes were first depleted 
from cellular debris by density gradient (Ficoll Hypaque, Pharmacia, 
Uppsala, Sweden) centrifugation, then labelled with DiOCr(3) and 
HE. Lymphocytes with normal size were gated on via the forward 
light scatter and cell populations were sorted on an Elite cytofluorom- 
eter (Becton and Dickinson, San Jos~, CA; windows as in Fig. 1) to 
be recovered in complete medium on ice. Cells were incubated in the 
presence or absence of cyclosporin A (1-10 ~tM, Sandoz), N-methyl- 
Val-4-cyclosporin A (SDZ 220-384, kindly provided by Dr. Roland 
Wenger, Sandoz AG, Basel, Switzerland) and/or bongkrekic acid 
(BA; purified as described in [26] and kindly provided by Dr. Duine; 
Delft University of Technology, Delft, Netherlands) for 15 min at 
4°C, followed by a brief culture period (1 h at 4 or 37°C), relabeling 
with DiOCr(3) and HE (see above) and reanalysis on the Elite cyto- 
fluorometer. Alternatively, cells were cultured for 4 h in the absence 
or presence of 50 ttM BA, followed by ethanol fixation and PI stain- 
ing. 
3. Results and discussion 
3.1. A cyclosporin A-inhibitable step of AUxJm reduction accom- 
panies apoptosis 
12 h after injection of a lymphocyte-depleting dose of the 
glucocorticoid receptor agonist dexamethasone (DEX), splen- 
ic cellularity decreases. One particularity of this in vivo system 
of apoptosis induction is that DEX-primed splenocytes fail to 
exhibit alterations associated with late apoptosis uch as chro- 
matinolysis and DNA fragmentation. This can be explained 
by the effective limination of dying lymphocytes before end- 
stage apoptosis is attained [23]. When compared to sham-trea- 
ted controls, a relatively high percentage of DEX-primed sple- 
nocytes exhibits a low AHrn, as measured by means of the 
cationic lipophilic fluorochrome DiOCr(3) ([3] and Fig. 1). 
Such AHl°J cells can be subdivided into two subpopulations, 
one subpopulation which behaves like AH~ gh cells in the sense 
that it is incapable of oxidizing hydroethidine (HE) to the 
fluorescent product ethidium (Eth), and another which is 
characterized by even lower AHm levels and an enhanced ca- 
pacity of HE--* Eth conversion (HE + cells). This HE ~ Eth 
conversion reflects mitochondrial superoxide anion generation 
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Fig. 2. Comparison of the A~Pm-modulatory and immunosuppressive effects of CsA and of N-methyl-Val-4-CsA. (A) Effect of CsA and N- 
methyl-Val-4-CsA (SDZ 220-384) on the A~Pm reduction accompanying DEX-induced apoptosis. DEX-primed splenocytes were sorted cytofluor- 
ometrically into three normal-sized populations: DiOCr(3)hlghHE-, DiOCr(3)l°wHE -, and DiOCr(3)I°WHE + cells, followed by in vitro culture 
(1 h, 37°C), relabeling and reanalysis (manipulation similar to that in Fig. 1). The transition to the immediately posterior stage of pre-apoptosis 
is indicated (X+S.E.M. of triplicates). Moreover, the 'resealing effect' (restablishment of a normal DiOCr(3) incorporation among 
DiOCr(3)I°wHE - cells) is quantitated (hatched columns). Background values obtained in control cultures kept at 4°C (Fig. 1A) were subtracted 
from experimental values. (B) Dose response of proliferation-inhibitory effects of CsA and N-methyl-Val-4-CsA. Mouse splenocytes were stimu- 
lated with the T cell mitogen concanavalin A (2 ~tg/ml) in the presence of the indicated amount of CsA or N-methyl-Val-4-CsA. Results are ex- 
pressed as % inhibition of [3H]thymidine uptake. Unsuppressed control values were 44+ 5 x 104 cpm. 
[27], since inhibition of the respiratory chain abolishes HE- 
Eth conversion [3,8]. Purification of these cell populations 
in a fluorescence-activated c ll sorter, followed by short-term 
in vitro culture at 37°C (not at 4°C), relabeling and reanalysis, 
reveals the following developmental sequence: 
DiOCr(3)highHE - --~ DiOC~(3)lOWHE - -~ DiOCr(3)1°WHE +. 
We have tested the effect of cyclosporin A (CsA) on this series 
of events and observed that CsA markedly inhibits the ad- 
vancement of DiOC6(3)highHE - to the DiOC6(3)I°WHE - 
stage. In contrast, CsA fails to affect the transition from the 
DiOCr(3)I°WHE - to the DiOCr(3)l°WHE + stage. However, it 
does cause a A~m increase in a significant percentage of 
DiOCr(3)I°WHE - cells, which thus re-acquire a normal, 
DiOC6(3)highHE - phenotype (Fig. 1). 
These observations recall the known effect of CsA on 'per- 
meability transition' (PT) of isolated mitochondria, s well as 
of mitochondria in anoxia-damaged cells. CsA is considered 
as a prototypical inhibitor of mitochondrial PT [14,28-30]. 
Moreover, CsA causes a phenomenon of mitochondrial mem- 
brane hyperpolarisation [31] and 'resealing' [30], i.e. it closes 
already open PT pores of isolated mitochondria nd thus 
allows for the restablishment of an intact electrochemical gra- 
dient. 
3.2. A non-immunosuppressive cyclosporin analog inhibits the 
apoptosis-associated A~Pm loss 
The PT-inhibitory effect of CsA is not mediated via calci- 
neurin [14,28-30,32], one of the principal target molecules 
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Fig. 3. Effect of bongkrekic acid (BA) on the A~/J m reduction ac- 
companying DEX-induced apoptosis. DiOC6(3)/HE-labelled spleno- 
cytes from DEX-primed mice belonging to three different subpopu- 
lations were purified and cultured for 1 h at 37°C in the presence 
or absence of the indicated oses of BA. 
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Fig. 4. Effect of BA on purified cells with different A~,~ values. 
DiOC~(3)highHE - and DiOC6(3)I°'VHE - splenocytes from a DEX- 
primed mouse were purified as in Fig. 1, followed by culture of cells 
at 4 or 37°C for 4 h, ethanol fixation and determination f DNA 
content after labelling with propidium iodine. During this period of 
culture, cells were kept in the presence or absence of BA. Percen- 
tages refer to the portion of hypoploid cells in each preparation 
(range of duplicates). Results are representative of three independent 
experiments. 
synthetic CsA derivative, N-methyl-Val-4-cyclosporin A (SDZ 
220-384), which binds cyclophilin and inhibits PT [30] but has 
rather limited calcineurin-dependent ffects [34], does inhibit 
the DEX-induced AWm loss of T lymphocytes and stimulates a 
resealing-like effect in DiOC~(3)I°WHE - cells (Fig. 2A). At the 
dose at which N-methyl-Val-4-CsA exerts these effects (300 
nM), it does not inhibit T cell proliferation in vitro (Fig. 
2B). In conclusion, the immunosuppressive and A~m-modula- 
tory effects of CsA can be dissociated. These observations are 
compatible with the idea that PT could constitute the mechan- 
ism by which pre-apoptotic cells lose their AVm. Although 
CsA and its analogue are efficient inhibitors of apoptotic 
A~m reduction in short-term experiments (30 to maximally 
60 min), it fails to maintain the AWm during longer incubation 
periods (not shown). This finding is again in accord with 
several studies [14,20,28] reporting that the pharmacological 
effects of CsA on PT are transitory. To demonstrate 
the involvement of PT in apoptosis, we thus were forced to 
employ an alternative inhibitor of PT, bongkrekic acid (BA) 
[35]. 
3.3. Bongkrekic acid, a specific ligand of  the adenine nucleotide 
translocator, inhibits the apoptotic ARJm dissipation and 
inhibits the loss of nuclear DNA in A~F'°m w cells 
BA is known to affect the molecular conformation of the 
ANT, thereby reducing the probability of PT pore gating [36- 
40]. BA prevents the A~Fm reduction, as do CsA and N- 
methyl-Val-4-CsA (Fig. 3). As do the two other PT inhibitors, 
CsA and N-methyl-Val-4-CsA, BA induces a resealing-like 
phenomenon, i.e. it enhances the A~rn of AW~ °w cells, provided 
that these have still a normal HE-  phenotype (Fig. 3). This 
latter effect is only elicited at relatively high concentrations of
BA (-> 100 ~tM), whereas the AWm-stabilizing effect is observed 
at 50 IxM. None of the PT inhibitors is capable of normalizing 
the AqJm of HE + cells, nor do they impede mitochondrial 
ROS generation (Figs. 2A,3). In synthesis, this set of data is 
compatible with the hypothesis that opening of PT pores 
might account for the apoptotic Aq'm disruption. 
If AqJlm °w DEX-primed splenocytes are purified cytofluoro- 
metrically (as described in Fig. 1, window 2) and cultured in 
vitro for 4 h at 37°C, they rapidly undergo apoptotic hro- 
matinolysis, and this phenomenon is not inhibited by BA 
(Fig. 4). In contrast, BA partially inhibits the DNA fragmen- 
tation of purified A~m~gh cells (Fig. 4). Thus, a AWm-stabilizing 
dose of BA prevents nucleolysis in cells in which the AWm 
reduction has not yet occurred (Fig. 4). 
3.4. Concluding remarks 
As pointed out in section 1, AWm disruption appears to be 
the earliest alteration of cellular biochemistry that constitutes 
a constant feature of pre-apoptotic cells [1-7]. Here, we pro- 
vide evidence suggesting that this ARJm reduction is a conse- 
quence of mitochondrial PT, a phenomenon that has been 
studied for decades in isolated mitochondria without its phy- 
siological function having become clear [14,15]. The hypoth- 
esis that apoptotic AWm reduction would result from PT is 
supported by the finding that both CsA and bongkrekic 
acid (BA), two well-known inhibitors of PT, efficiently prevent 
the apoptosis-associated fall in A~m. BA and cyclophilin li- 
gands (CsA and N-methyl-Val-4-CsA) also restablish the AWm 
in pre-apoptotic cells, provided that they are still HE- .  In 
contrast, they fail to restore the Aq'm of HE + cells. The rea- 
sons for this selective ffect are not clear. We have previously 
shown that HE-detectable generation of superoxide anion 
causes the oxidation of inner mitochondrial membrane cardi- 
olipin [8], which, in turn, is essential for the function of at 
least one of the PT pore components, the ANT [41]. Thus, the 
HE-- stage marks a truly irreversible stage of self-inflicted 
mitochondrial destruction. 
As to the localization of the point-of-no-return of the apop- 
totic cascade, a number of observations indicate that this 
point coincidates with AWm disruption. This is suggested by 
the fact that mitochondria which are undergoing PT in vitro 
release a protein capable of inducing chromatin condensation 
and DNA fragmentation i isolated nuclei [42]. Moreover, 
AI]/~ gh cells can be rescued from apoptosis by withdrawal of 
the apoptosis-inducing stimulus [3] or inhibition of AVm dis- 
ruption (this paper), whereas the same manipulations do not 
delay the death of AW~ w cells. In conclusion, our data suggest 
that apoptotic AR'm dissipation is mediated by PT and that 
interventions on PT can modulate apoptosis. 
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